Hemophilia Growth and Development Study: Baseline Neurodevelopmental Findings

Reported baseline findings from the neurological assessment component of the Hemophilia Growth and Development Study (HDGS). HIV-positive (n=207) and HIV-negative (n=126) young males with hemophilia aged 6 to 18 years, were enrolled in a prospective study of their growth and development. At baseline, HIV+ and HIV- subjects were not significantly different in test performance.